HDAC9 and cancer: For example, p300/CBP HAT-acetylases catalyze acetylation of the p53 transcription factor, which could cause up-regulation of the p53-positive feedback loop (Gu and Roeder, 1997), which is a concerning outcome complicating the anti-cancer activity of HAT and HDAC inhibitors.